Cargando…

New closed-loop insulin systems

Advances in diabetes technologies have enabled the development of automated closed-loop insulin delivery systems. Several hybrid closed-loop systems have been commercialised, reflecting rapid transition of this evolving technology from research into clinical practice, where it is gradually transform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boughton, Charlotte K., Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012332/ https://www.ncbi.nlm.nih.gov/pubmed/33550442 http://dx.doi.org/10.1007/s00125-021-05391-w

Ejemplares similares

Correction to: New closed-loop insulin systems
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Closed-loop management of inpatient hyperglycemia
por: Boughton, Charlotte K., et al.
Publicado: (2019)

Training and Support for Hybrid Closed-Loop Therapy
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Closed-loop insulin delivery for treatment of type 1 diabetes
por: Elleri, Daniela, et al.
Publicado: (2011)

Closed‐loop insulin delivery in end‐of‐life care: a case report
por: Boughton, C. K., et al.
Publicado: (2019)

The changing landscape of automated insulin delivery in the management of type 1 diabetes
por: Lakshman, Rama, et al.
Publicado: (2023)

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
por: Daly, Aideen B., et al.
Publicado: (2023)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery
por: Ruan, Yue, et al.
Publicado: (2015)

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
por: Boughton, Charlotte K, et al.
Publicado: (2019)

Publisher Correction: Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Data Sharing While Using a Closed-Loop System: Qualitative Study of Adolescents' and Parents' Experiences and Views
por: Lawton, Julia, et al.
Publicado: (2021)

What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial
por: Kimbell, Barbara, et al.
Publicado: (2020)

Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery
por: Krutkyte, Gabija, et al.
Publicado: (2023)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Can exenatide flatten the post-prandial glucose curve in type 1 diabetes?
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
por: Murphy, Helen R., et al.
Publicado: (2011)

Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
por: Fuchs, Julia, et al.
Publicado: (2021)

Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series
por: Daly, Aideen, et al.
Publicado: (2021)

Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England
por: Farrington, Conor, et al.
Publicado: (2020)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
por: Hood, Korey K., et al.
Publicado: (2022)

Adolescents’ Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study
por: Rankin, David, et al.
Publicado: (2021)

A qualitative study of clinician attitudes towards closed‐loop systems in mainstream diabetes care in England
por: Farrington, C., et al.
Publicado: (2020)

A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
por: Peacock, Sofia, et al.
Publicado: (2023)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial
por: Schierloh, Ulrike, et al.
Publicado: (2019)

Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
por: Tauschmann, Martin, et al.
Publicado: (2016)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
por: Hovorka, Roman, et al.
Publicado: (2011)

Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers’ Fear of Hypoglycemia and Improves Their Well-being
por: de Beaufort, Carine, et al.
Publicado: (2022)

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
por: Elleri, Daniela, et al.
Publicado: (2014)

Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions
por: Templer, Sophie
Publicado: (2022)

Adolescents’ and their parents’ experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study
por: Rankin, D, et al.
Publicado: (2021)

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
por: Musolino, Gianluca, et al.
Publicado: (2019)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9ftn36gi9o0e1e674kugip7i7c